AstraZeneca, Toshiba, and happy staff

Today Ian King is discussing COVID vaccine maker AstraZeneca’s decision to move away from its at-cost model and aim to make a “modest profit” from the jabs.

:: Listen and subscribe to The Ian King Business Podcast here.

He’s also investigating the break-up of Toshiba, and is joined by the maker of an app which aims to make employees happier.